RPE65 and Leber congenital amaurosis: In patients affected by Leber’s congenital amaurosis and RP caused by mutations in the RPE65 gene, successful gene therapy clinical trials have been completed, in which a viral vector containing the RPE65 transgene was injected into the subretinal space [9,10].